Concepedia

Kévin Ly

KL

Statistics

Publications

16

Citations

1K

H-Index

14

Active since

2009

Affiliations

Université de Sherbrooke(Current)

Montreal Clinical Research Institute

Université de Montréal

Beckman Research Institute

Boston Children's Hospital

Kévin Ly is an author at Université de Sherbrooke specializing in life sciences, cell signaling, and molecular biology.

ORCID

Publications per year

2009–2024

16

Publications

16

Combining PARP with ATR inhibition overcomes PARP inhibitor and platinum resistance in ovarian cancer models

Hyoung Kim, Haineng Xu, Erin George et al. · Nature Communications · 2020 · 369 citations · Full text

, , +17

Dissection of the Endogenous Cellular Pathways of PCSK9-induced Low Density Lipoprotein Receptor Degradation

Steve Poirier, Gaétan Mayer, Viviane Poupon et al. · Journal of Biological Chemistry · 2009 · 266 citations · Full text

, , +12

Hyperglycosylation of prosaposin in tumor dendritic cells drives immune escape

Pankaj Sharma, Xiaolong Zhang, Kévin Ly et al. · Science · 2024 · 68 citations · Full text

, , +17

Long-term tolerance to skin commensals is established neonatally through a specialized dendritic cell subgroup

Antonin Weckel, Miqdad O. Dhariwala, Kévin Ly et al. · Immunity · 2023 · 57 citations · Full text

, , +14

Ser-Phosphorylation of PCSK9 (Proprotein Convertase Subtilisin-Kexin 9) by Fam20C (Family With Sequence Similarity 20, Member C) Kinase Enhances Its Ability to Degrade the LDLR (Low-Density Lipoprotein Receptor)

Ali Ben Djoudi Ouadda, Marie-Soleil Gauthier, Delia Susan‐Resiga et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2019 · 55 citations · Full text

, , +16

1–5 of 16